Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
id: 891

NexImmune (NEXI) Stock Halted Case

  • On December 1st, 2023, $NEXI surged over 300%, leading Nasdaq to halt trading.
  • NexImmune has faced a significant decline since its 2021 IPO.
  • With concerns about dissolution, $NEXI didn't trade on Friday.
NexImmune proposes on December 21 meeting for shareholder approval of liquidation. The board unanimously supports dissolution after evaluating strategic options and the company's financial status.

Trouble emerged in September with NexImmune reducing its workforce and pausing clinical trials.

Despite this, $NEXI surged 35% between November 27 and 30, prompting Nasdaq's intervention.
Case Status
Attorney Investigation
Alleged Offence
Misleading Statements
Suspected Party
Security Type
Trade Direction
Shock Event Date
01 December 2023
Collecting participants…